SmartBreast Corporation, Inc.

SmartBreast Corporation manufactures and distributes Molecular Breast Imaging (MBI) systems for early-stage breast cancer detection in women with dense breast tissue. MBI uses FDA-cleared gamma camera technology with tracer molecules to detect cancers with 94% sensitivity in dense breasts, compared to 30% for conventional mammography. The company offers a painless, minimally invasive alternative to traditional mammography and digital breast tomosynthesis, with systems installed and serviced across 12 countries. SmartBreast targets healthcare facilities and diagnostic imaging centers seeking superior cancer detection rates while reducing patient discomfort and radiation exposure in dense breast screening protocols.